切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2011, Vol. 05 ›› Issue (01) : 68 -74. doi: 10.3877/cma.j.issn.1674-0793.2011.01.020

所属专题: 专题评论 文献

循证医学

恶性梗阻性黄疸术前减黄利弊的系统评价
徐晨1, 夏金堂1,(), 徐波1, 蔡文松1, 赖越元1, 伍兆锋1   
  1. 1. 510180 广州,广州医学院附属广州市第一人民医院肝胆外科
  • 收稿日期:2010-09-29 出版日期:2011-02-01
  • 通信作者: 夏金堂

Effectiveness of preoperative biliary drainage for malignant obstructive jaundice: a systematic review and meta-analyses of randomized controlled trials

Chen XU1, Jin-tang XIA1,(), Bo XU1, Wen-song CAI1, Yue-yuan LAI1, Zhao-feng WU1   

  1. 1. Department of Hepatobiliary Surgery, the Affiliated Guangzhou First Municipal People's Hospital, Guangzhou Medical College, Guangzhou 510180, China
  • Received:2010-09-29 Published:2011-02-01
  • Corresponding author: Jin-tang XIA
  • About author:
    Corresponding author: XIA Jin-tang, Email:
引用本文:

徐晨, 夏金堂, 徐波, 蔡文松, 赖越元, 伍兆锋. 恶性梗阻性黄疸术前减黄利弊的系统评价[J/OL]. 中华普通外科学文献(电子版), 2011, 05(01): 68-74.

Chen XU, Jin-tang XIA, Bo XU, Wen-song CAI, Yue-yuan LAI, Zhao-feng WU. Effectiveness of preoperative biliary drainage for malignant obstructive jaundice: a systematic review and meta-analyses of randomized controlled trials[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2011, 05(01): 68-74.

目的

系统评价恶性梗阻性黄疸患者术前行胆道引流(preoperative biliary drainage, PBD)的利弊。

方法

计算机检索Cochrane Library、PubMed、EMBASE、中国生物医学文献数据库等数据库,并辅以手工检索,截止到2010年6月。对纳入的随机对照试验用RevMan5.0软件进行Meta分析。

结果

纳入7个随机对照试验,Meta分析结果显示:与对照组比较,PBD组术后死亡率(P=0.88)和总并发症发生率(P=0.66)的差异无统计学意义;采用经皮肝穿胆道引流(PTBD)(OR=0.49,95% CI = 0.31~0.79,P=0.003)、引流前血清总胆红素>200 μmol/L(OR=0.56,95% CI=0.37~0.84,P=0.006)、引流时间小于4周(OR=0.60,95% CI=0.39~ 0.93,P=0.020)的患者术后并发症发生率降低。

结论

选择合适的病例,采取合适的引流方式,控制合适的引流时间,术前减黄可降低恶性梗阻性黄疸患者术后并发症发生率,但不能降低术后死亡率和总并发症发生率。

Objective

To determine the benefits and harms of preoperative biliary drainage (PBD) in malignant obstructive jaundice.

Methods

The Cochrane Library, PubMed, EMBASE, Chinese Biomedical Literature Database were searched up to June 2010 added with handsearching and other retriecals. The Cochrane Collaboration’s RevMan 5.0 was used for Meta-analyses.

Results

Seven RCTs were included. Meta-analyes showed no significant difference of mortality (P=0.88) and overall morbidity (P=0.66) between PBD group and controlled group. Lower postoperative morbidity was found in percutaneous transhepatic biliary drainage (PTBD) group(OR=0.49, 95% CI=0.31-0.79, P=0.003), the patients with high bilirubinemia (serum total bilirubin>200 μmol/L) (OR=0.56, 95% CI=0.37-0.84, P=0.006) and PBD less than 4 weeks (OR=0.60, 95% CI=0.39-0.93, P=0.02) significantly.

Conclusions

Selecting the appropriate cases, taking appropriate drainage way, controlling proper drainage time, PBD could decrease postoperative morbidity of malignant obstructive jaundice but has no significant beneficial effect on mortality and overall morbidity.

表1 纳入研究文献的一般情况
表2 纳入研究文献的质量评价(Jadad评分)
图1 7个RCT术后死亡率的Meta分析
图2 总并发症发生率的Meta分析
图3 术后并发症发生率的Meta分析:PBD组与直接手术组的比较
图4 术后并发症的Meta分析:PTBD、ERBD组与直接手术组的比较
图5 术后并发症的Meta分析:按引流前不同黄疸程度分组
图6 术后并发症的Meta分析:减黄少于4周组与直接手术组的比较
1
Gouma DJ, van Geenen RC, van Gulik TM, et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg, 2000, 232(6): 786-795.
2
Whipple AO, Parsons WB, Mullins CR, et al. Treatment of carcinoma of the ampulla of Vater. Ann Surg, 1935, 102(4): 763-779.
3
Nakayama T, Ikeda A, Okuda K, et al. Percutaneous transhepatic drainage of the biliary tract: technique and results in 104 cases. Gastroenterology, 1978, 74(3): 554-559.
4
Gundry SR, Strodel WE, Knol JA, et al. Efficacy of preoperative biliary tract decompression in patients with obstructive jaundice. Arch Surg, 1984, 119(6): 703-708.
5
McPherson GA, Benjamin IS, Hodgson HJ, et al. Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg, 1984, 71(5): 371-375.
6
Pitt HA, Gomes AS, Lois JF, et al. Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost?. Ann Surg, 1985, 201(5): 545-553.
7
三浦修, 羽生富士夫, 今泉俊秀, 等.术前减黄处置の功罪. 胆と胰, 1989, 10(3): 561-564.
8
沈魁, 田雨霖, 慈福承, 等. 恶性梗阻性黄疸术前减黄的利弊和方法. 中华外科杂志, 1991, 29(1): 56-58.
9
Sewnath ME, Karsten TM, Prins MH, et al. A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg, 2002, 236(1): 17-27.
10
Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials, 1996, 17(1): 1-12.
11
Hatfield AR, Tobias R, Terblanche J, et al.Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet, 1982, 2(4): 896-899.
12
Lai EC, Mok FP, Fan ST, et al. Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg, 1994, 81(8): 1195-1198.
13
Wig JD, Kumar H, Suri S, et al. Usefulness of percutaneous transhepatic biliary drainage in patients with surgical jaundice-a prospective randomised study. J Assoc Physicians India, 1999, 47(3): 271-274.
14
田伏洲, 石力, 汤礼军, 等. 胰头癌术前减黄指征的前瞻性研究. 中华外科杂志, 2006, 44(23): 1614-1616.
15
van der Gaag NA, Rauws EA, van Eijck CH, et al. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med, 2010, 362(2): 129-137.
16
田伏洲, 石力, 汤礼军, 等. 对恶性梗阻性黄疸术前减黄指标的再认识(附28例临床分析). 中国现代普通外科进展, 2010, 13(1): 1-4.
17
何晓东, 康维明. 恶性梗阻性黄疽的术前减黄与Ⅱ期手术. 中国医刊, 2002, 37(12): 14-16.
18
Mansfield SD, Barakat O, Charnley RM, et al. Management of hilar cholangiocarcinoma in the North of England: pathology, treatment, and outcome. World J Gastroenterol, 2005, 11(48): 7625-7630.
19
Hochwald SN, Burke EC, Jarnagin WR, et al. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg, 1999, 134(3): 261-266.
20
Hemming AW, Reed AI, Fujita S, et al. Surgical management of hilarcholangiocarcinoma. Ann Surg, 2005, 241(5): 699-702.
[1] 蚁淳, 袁冬生, 熊学军. 系统免疫炎症指数与骨密度降低和骨质疏松的关联[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 609-617.
[2] 李志文, 李远志, 李华, 方志远. 糖皮质激素治疗膝骨关节炎疗效的网状Meta分析[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 484-496.
[3] 吴姗姗, 潘裕民, 刘晋, 张劲松, 乔莉. 睡眠呼吸暂停综合征患者静脉血栓栓塞症发生率的Meta分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 312-317.
[4] 程鹏, 杨道鸿, 邓文君, 钟宇琼, 胡晓雪, 黄小银, 周道扬. 纤维蛋白原治疗创伤性凝血病有效性和安全性的Meta分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(03): 225-231.
[5] 沈皓, 张驰, 韩旻轩, 陆晓庆, 周愉, 周莉丽. 骨皮质切开术对正畸治疗牙根吸收影响的Meta分析[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(03): 175-184.
[6] 郭仁凯, 武慧铭, 李辉宇. 机器人辅助全系膜切除术治疗右半结肠癌有效性和安全性的Meta分析及试验序贯分析[J/OL]. 中华普通外科学文献(电子版), 2024, 18(03): 234-240.
[7] 朱俊佳, 孙琦, 徐文龙, 陆天宇, 冯强, 储涛, 邢春根, 高春冬, 俞一峰, 赵振国. 永久性结肠造口预防性补片置入对预防造口旁疝价值的Meta分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(03): 336-342.
[8] 王招荐, 曹桢, 郭小双, 靳小雷, 刘子文. 加速康复外科理念应用于腹壁重建手术的系统评价及Meta分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(03): 343-350.
[9] 马振威, 宋润夫, 王兵. ERCP胆道内支架与骑跨十二指肠乳头支架置入治疗不可切除肝门部胆管癌疗效的Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 807-812.
[10] 龚财芳, 赵俊宇, 游川. 围手术期肠内营养在肝癌肝切除患者中有效性及安全性的Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 551-556.
[11] 郁凯, 曾保起, 杨剑, 杨杰, 张殿英, 孙凤. 全关节镜与切开手术治疗肩袖撕裂疗效比较的系统综述与Meta分析[J/OL]. 中华肩肘外科电子杂志, 2024, 12(03): 238-245.
[12] 史敬萱, 焦圆圆, 田景玮, 卓莉. 间充质干细胞来源外泌体治疗动物糖尿病肾脏病的效果:Meta分析[J/OL]. 中华肾病研究电子杂志, 2024, 13(02): 79-86.
[13] 王芳, 刘达, 左智炜, 盛金平, 陈庭进, 蒋锐. 定量CT与双能X线骨密度仪对骨质疏松诊断效能比较的Meta分析[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 363-371.
[14] 陈华, 张欣颖, 潘婕, 周平达, 韩千禧, 杨倩, 朱文涛. 芪蓉润肠口服液系统评价研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(03): 263-267.
[15] 周倩妹, 王宪娥, 徐筱, 老慧琳, 赵欣悦, 胡菁颖. 多元化系统护理对老年人群牙周健康指标影响的系统评价[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 500-506.
阅读次数
全文


摘要